Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

A study led by bioengineers at the University of California San Diego sheds new light on how a type of heart valve disease, called aortic valve stenosis, progresses differently in males and females.

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and can lead to a domino effect of life-saving procedures.

CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of ...

Dr Rajneesh Kapoor highlights the evolution of structural heart disease treatments, exploring the impact of transcatheter ...

The Duke team performed the world’s first living mitral valve replacement, a type of partial heart transplant, which Duke ...

Loma Linda University Children's Hospital recently made history performing the first pediatric partial heart transplant in ...

Laplace has raised $22m in a Series C financing round to support the completion of EFS of transcatheter tricuspid valve technology.

Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare ...